Details
Category: Volume 07 Issue 06 June 2019
Hits: 1405

Title: Diagnostic Role of RDW & PDW as Early Markers of Sepsis in Chemotherapy Induced Febrile Neutropenia

Authors: Nitin Mohan, Veni Prasanna Gedela, Murali Krishna Voona, Viswa Kalyan Kolli

 DOI: https://dx.doi.org/10.18535/jmscr/v7i6.52

Abstract

Introduction: Febrile neutropenia is commonly seen in patients undergoing chemotherapy that makes them susceptible to infections. Procalcitonin (PCT) is routinely used as a marker of systemic infections. Recently, Red Cell Distribution Width (RDW) and Platelet Distribution Width (PDW) were also indicated for the presence of infections. The aim of the study was to find the clinical utility of RDW and PDW along with PCT as biomarker for early institution of antibiotic therapy.

Materials & Methods: 150 patients with haematological malignancies who had chemotherapy-induced neutropenia were included in the study and were tested for PCT, RDW and PDW.

Results: 42 patients who tested negative for PCT were considered as Control and the 108 patients who tested positive for PCT were considered as Test. RDW and PDW values were significantly increased in the test group (RDW: 51.9+10.29 and PDW: 12.2+3.56)as compared to the control group (RDW (SD): 43.49+7.98 and PDW: 10.76+1.78).

Conclusion: RDW and PDW together with PCT can be used as biomarker for sepsis and early institution of antibacterial therapy.

Keywords: Procalcitonin (PCT); Red Cell Distribution Width (RDW); Platelet Distribution Width (PDW); Sepsis.

References

  1. Liu HH, Guo JB, Geng Y, Su L. Procalcitonin: present and future. Ir J Med Sci.2015;184(3): 597–605.
  2. Miyamoto K, Inai K, Takeuchi D, Shinohara T and Nakanishi T. Relationships among red cell distribution width, anemia and inter­leukin‑6 in adult congenital heart disease. Circ J. 2015;79(5):1100‑1106.
  3. Kasperska‑Zajac A, Grzanka A, Jarzab J, Misiołek M, Wyszyńska‑Chłap M, Kasperski J, Machura E. The association between platelet count and acute phase response in chronic spontaneous urticaria. Biomed Res Int. 2014;2014:650913.
  4. Ku NS, Kim HW, Oh HJ, Kim YC, Kim MH, Song JE, et al. Red blood cell distribution width is an independent predictor of mortality in patients with gram‑negative bacteremia. Shock. 2012;38(2):123-127.
  5. Celik A, Aydin N, Ozcirpici B, Saricicek E, Sezen H, Okumus M, et al. Elevated red blood cell distribution width and inflammation in printing workers. Med Sci Monit. 2013;19:1001‑1005.
  6. Lippi G, Targher G, Montagnana M, Salvaqno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133(4):628–632.
  7. Kucukbayrak A, Tas T, Tosun M, Aktas G, Hakyemez IN, Mengeloglu FZ. Erythrocytes parameters in the course of Brucellosis. Abant Med J. 2013;2(1):36–38.
  8. Ahmad MS, Waheed A. Platelet counts, MPV and PDW in culture proven and probable neonatal sepsis and association of platelet counts with mortality rate. J Coll Physicians Surg Pak. 2014;24(5):340-344.
  9. Abdel-Razik A, Eldars W, Rizk E.  Platelet indices and inflammatory markers as diagnostic predictors for ascitic fluid infection. Eur J Gastroenterol Hepatol. 2014;26(12):1342-1347.
  10. Orak M, Karakoç Y, Ustundag M, Yildirim Y, Celen MK, Güloglu C. An investigation of the effects of the mean platelet volume, platelet distribution width, platelet/lymphocyte ratio, and platelet counts on mortality in patents with sepsis who applied to the emergency department.  Niger J ClinPract. 2018;21(5):667-671.
  11. Rebello A, Thabah MM, Dutta TK, Bobby Z, Harish BN, Mehalingam V. Procalcitonin levels in sepsis and its association with clinical outcome in southern India. Trop Doct. 2017;47(4):331-336.
  12. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009; 302(10): 1059–1066. 
  13. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentrerandomised controlled trial. Lancet. 2010;375(9713):463-474.
  14. Schuetz P, Bretscher C, Bernasconi L, Mueller B. Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis. Expert Rev MolDiagn. 2017;17(6):593-601.
  15. Zhang HB, Chen J, Lan QF, Ma XJ, Zhang SY. Diagnostic values of red cell distribution width, platelet distribution width and neutrophil-lymphocyte count ratio for sepsis. ExpTher Med. 2016;12(4):2215-2219.

Corresponding Author

Dr Viswa Kalyan Kolli

Associate Professor, Department of Biochemistry, GITAM Institute of Medical Sciences & Research, GITAM (Deemed to be University),  Rushikonda, Visakhapatnam – 530045. Andhra Pradesh. India